Consolidated Planning Corp’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.4M | Buy |
50,313
+1,133
| +2% | +$122K | 0.68% | 49 |
|
|
2025
Q1 | $4.96M | Buy |
49,180
+407
| +0.8% | +$41.1K | 0.68% | 47 |
|
|
2024
Q4 | $4.36M | Buy |
48,773
+1,018
| +2% | +$90.9K | 0.59% | 56 |
|
|
2024
Q3 | $4M | Buy |
47,755
+3,429
| +8% | +$287K | 0.6% | 56 |
|
|
2024
Q2 | $3.41M | Buy |
+44,326
| New | +$3.41M | 0.56% | 56 |
|
|
2021
Q4 | – | Sell |
-534
| Closed | -$23K | – | 116 |
|
|
2021
Q3 | $23K | Buy |
+534
| New | +$23K | 0.01% | 236 |
|